Angela Buonadonna

10PUBLICATIONS
41CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients' Sex.

|May 11, 2024
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.

Gianmaria Miolo, Wally Marus, Angela Buonadonna

|Nov 13, 2023
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

Sara Gagno, Chiara Dalle Fratte, Bianca Posocco

|Oct 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.

Angela Buonadonna, Simona Scalone, Davide Lombardi

|Oct 27, 2023
Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin.

Gianmaria Miolo, Angela Buonadonna, Simona Scalone

|Feb 25, 2023
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno

Pageof 2

Frequent Collaborators

6 joint publications

Fabio Puglisi

4 joint publications

Erika Cecchin

4 joint publications

Michela Guardascione

3 joint publications

Gianmaria Miolo